Home >Results of Submissions >Late-breaking clinical trial
Late-breaking clinical trial

    CIT Late-Breaking Clinical Trials are first-time worldwide presentations of the primary endpoint or important secondary endpoint results of prospective, randomized clinical trials, or the first worldwide presentations of large-scale, impactful single-center or multi-center registries, or first-in-man experiences with novel devices or drugs.

     

    Studies accepted as Late-Breaking Clinical Trials will be presented in the Main Arena at CIT 2011 on Thursday, March 17, 2011. An application must be submitted for each Late-Breaking Clinical Trial that you are proposing. By submitting an application, you are warranting that the trial or study is likely to be completed and will be presented at CIT if accepted, whether the results are positive or negative. Presentations of accepted Late-Breaking Clinical Trials prior to CIT are strictly embargoed.


    Note: Accepted Late-Breaking Clinical Trials may not be withdrawn for negative results. Such action will negatively impact future applications from both the applicant and the trial sponsor.

    Submission Criteria and Specifications

    ●    Submission indicates that the clinical trial or study is likely to be completed by
          CIT2011
    ●    Accepted submissions will be presented at CIT, whether the results are positive
          or negative. (Accepted late breaking trials may  not be withdrawn for negative
          results)
    ●    Presentations of accepted late breaking trials prior to CIT are strictly embargoed
    ●    Physicians whose clinical trial or study is accepted for presentation become CIT
          faculty and their registration fees are waived


    Please download the Application Form from the CIT website (www.citmd.com/CIT/2011/down/Late_breaking_clinical_trial application.doc) , complete it and send to Dr. Bo Xu, Secretary General of CIT at  bxu@citmd.com  before December 18, 2010.
     

    Submission Deadline:
    December 18, 2010